Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...
Journal of Nuclear Medicine September 2024, jnumed.124.268151; DOI: https://doi.org/10.2967/jnumed.124.268151 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267489; DOI: https://doi.org/10.2967/jnumed.124.267489 ...
Journal of Nuclear Medicine September 2024, jnumed.124.268797; DOI: https://doi.org/10.2967/jnumed.124.268797 ...
Journal of Nuclear Medicine September 2024, jnumed.124.268011; DOI: https://doi.org/10.2967/jnumed.124.268011 ...